Maisha Meds is an organization dedicated to improving health care in Africa. We began full-time operations in 2017 and over the past few years has grown to support over 3million patient encounters annually across Kenya, Tanzania, Uganda, Nigeria, and Zambia with our suite of software products. We are building the financial and technology infrastructure to enable global health funders to pay for health outcomes at the last mile, with a focus on malaria case management (and results from a RCT with UC Berkeley due out later this year), injectable contraceptives, prenatal care, HIV pre-exposure prophylaxis, and COVID testing and vaccination.